| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
11 companies
Gordon Carl L is a Director, 10% Owner at ALEC with holdings across 11 companies. Recent SEC Form 4 filings include 17 buys and 9 sells.
Estimated insider holdings value: $415.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2025 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Sell | 3,571,428 | $1.59 | $5,678,570.52 | -100% | +51.4% | +211.4% | |
| Feb 18, 2025 | MBX Mbx Biosciences, Inc. | Director, 10% Owner | Buy | 190,672 | $10.60 | $2,020,755.60 | +1.9% | +11.5% | +269.8% | |
| Sep 16, 2024 | MBX Mbx Biosciences, Inc. | Director, 10% Owner | Buy | 750,000 | $16.00 | $12,000,000.00 | +24.5% | -11.6% | -55.0% | |
| Aug 13, 2024 | KROS Keros Therapeutics, Inc. | Director | Sell | 250,000 | $44.01 | $11,002,500.00 | -19.7% | +52.7% | -68.7% | |
| Jul 16, 2024 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 56,164 | $10.00 | $561,640.00 | -0.4% | -21.4% | -45.7% | |
| Jan 30, 2024 | AVBP Arrivent Biopharma, Inc. | Director, 10% Owner | Buy | 444,444 | $18.00 | $7,999,992.00 | +17.2% | -25.7% | +31.9% | |
| Jan 25, 2024 | ACET Adicet Bio, Inc. | Director, 10% Owner | Buy | 3,125,000 | $2.40 | $7,500,000.00 | +47.0% | -24.1% | -62.7% | |
| Jun 27, 2023 | ACET Adicet Bio, Inc. | Director, 10% Owner | Buy | 875,000 | $2.09 | $1,828,750.00 | +12.1% | -34.3% | -37.1% | |
| Dec 23, 2022 | TERN Terns Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 137,931 | $7.25 | $999,999.75 | +2.9% | +10.3% | -20.5% | |
| Nov 8, 2022 | CMPX Compass Therapeutics, Inc. | Director, 10% Owner | Buy | 402,000 | $3.21 | $1,290,420.00 | +2.7% | -7.3% | -59.5% |